News > Ivermectin drug: Study says regular use of oral anti-parasitic drug may cut risk of contracting Covid-19

Ivermectin drug: Study says regular use of oral anti-parasitic drug may cut risk of contracting Covid-19

Regular use of the oral antiparasitic drug ivermectin may significantly reduce the risk of contracting Covid-19, according to a review of available data by researchers who claim the medicine can help end the pandemic.

The research, published in the May-June issue of the American Journal of Therapeutics, is the most comprehensive review of the available data on ivermectin taken from clinical, in vitro, animal, and real-world studies, its authors said.